Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)
8.90
-0.12 (-1.33%)
Apr 30, 2025, 3:04 PM CST
SHE:300534 Revenue
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD had revenue of 289.44M CNY in the quarter ending March 31, 2025, with 13.52% growth. This brings the company's revenue in the last twelve months to 1.07B, up 3.36% year-over-year. In the year 2024, Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD had annual revenue of 1.04B, down -3.79%.
Revenue (ttm)
1.07B
Revenue Growth
+3.36%
P/S Ratio
2.51
Revenue / Employee
1.69M
Employees
634
Market Cap
2.70B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.04B | -40.98M | -3.79% |
Dec 31, 2023 | 1.08B | 280.37M | 35.06% |
Jan 1, 2023 | 799.68M | 511.87M | 177.85% |
Jan 1, 2022 | 287.81M | 32.91M | 12.91% |
Dec 31, 2020 | 254.90M | 15.90M | 6.65% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |